MyoVision inventor David Marcarian receives teaching appointment

(Nov. 10, 2020) — David Marcarian, MA, inventor of the DynaROM ROM-sEMG system, was honored with an appointment as Clinical Instructor at the University at Buffalo, Jacobs School of Medicine and Medical Sciences, teaching radiology students how to utilize DynaROM technology.

DynaROM is an FDA-cleared, class II medical device that effectively and objectively measures the impact of soft tissue injury by documenting pain in motion. Also known as Dynamic Range of Motion, DynaROM is a functional test that measures muscle guarding and range of motion at the same time the patient moves. By moving the patient, clinicians can effectively elicit measurable pain responses and guarding when soft tissue injury is present.

The Jacobs School of Medicine has been utilizing DynaROM technology along with MRI, CT and additional measures to evaluate the spine. According to Associate Professor Geoff Gerow, DC, “The DynaROM has revolutionized how we see the spine. Unlike an MRI or CT, by performing the test in motion, it provides us functional information not possible with static measures.”

With four National Institutes of Health Medpix Case Studies published on the NIH website, the DynaROM has proven a very powerful tool for this multidisciplinary group, which includes chiropractors, physical therapists and MDs.

“Mr. Marcarian has proven a tremendous asset in teaching the radiology students at University at Buffalo. His inventions, the DynaROM and ProformaVision, have proven extremely valuable in providing important functional information about each patient. He has proven himself an excellent teacher and his expertise in injury evaluation has provided us with a new paradigm for evaluating the spine,” said Gerow.

“This teaching appointment at the Jacobs School of Medicine at the University at Buffalo is a great honor,” said Marcarian. “This appointment helps validate that these devices created for evaluating the spine help all practitioners finally provide objective evidence proving that pain which was considered impossible to measure objectively is now measurable. My goal all along has been to ensure those in pain are treated appropriately, and those that are symptom magnifiers are redirected outside the workers compensation and personal injury systems. A true win-win for insurers, doctors, and ultimately patients.”

About MyoVision

A passion for excellence. A passion for innovation. A passion for quality. These are the driving forces behind the MyoVision success story. Developed under a prestigious NIH Grant, MyoVision is the result of thousands of hours of R&D and clinical application in areas from health care to sports medicine. With more than 80 patents, innovation has driven the success of MyoVision since its inception in 1989. Located in Seattle for the past 15 years, we strive for excellence on a daily basis. For more information, visit myovision.com.

About Jacobs School of Medicine at University at Buffalo

The Jacobs School of Medicine and Biomedical Sciences is in downtown Buffalo, on the Buffalo Niagara Medical Campus. Our building aligns our medical education, research and clinical care with our clinical and research partners — including Buffalo General Medical Center, the John R. Oishei Children’s Hospital, the Gates Vascular Institute, Roswell Park Comprehensive Cancer Center, Hauptman-Woodward Medical Research Institute and UBMD Physicians Group practices in Conventus. For more information, visit medicine.buffalo.edu.